期刊文献+

替米沙坦对高血压病患者血管内皮功能的影响 被引量:4

Effect of Telmisartan on Vascular Endothelial Function in Patients with Essential Hypertension
下载PDF
导出
摘要 目的 探讨替米沙坦对高血压病患者血管内皮功能的影响。 方法  46例轻、中度原发性高血压患者 ,给予替米沙坦 80mg/d ,共 6周。观察治疗前后的血浆内皮素 -1(ET -1)和一氧化氮 (NO)水平的变化。另设 40例为健康对照组。 结果 高血压病患者治疗前与对照组比较 ,其血浆ET -1水平明显升高 ,NO水平显著降低 ;经替米沙坦治疗后其ET -1明显下降 ,NO水平显著升高 ,与治疗前差别有显著性。 结论 替米沙坦能改善高血压病患者的血管内皮功能。 Objective To investigate the effect of Telmisartan on vascular endothelial function in patients with essential hypertension. Methods Forty-six patients with essential hypertension had been treated with 80mg Telmisartan per day for 6 weeks . Plasma ET-1 and NO were measured before and 6 weeks after treatment . Forty healthy adults served as controls. Result Before medication , ET-1 was higher and NO lower in treatment group than control group (P<0.05). In treatment group , ET-1 was significantly decreased and NO was significantly increased 6 weeks after treatment with Telmisartan (P<0.05) There was significant difference before and after treatment. Conclusion Telmisartan may improve the vascular endothelial function of patients with essential hypertension .
出处 《实用预防医学》 CAS 2004年第3期467-468,共2页 Practical Preventive Medicine
关键词 替米沙坦 原发性高血压 血管内皮功能 Telmisartan Essential hypertension Vascular endothelial function
  • 相关文献

参考文献9

  • 1Moclellan KJ,Markhan.Telmisartan,discussion[J].Drugs,1998,56(6):1045-1046.
  • 2Flavahan NA.Atherosclerosis or cholesterol - induced endothelial dysfunction[J]. Circulation,1992,85(5):1927-1938.
  • 3DeMeyer. GR, Herman AG. Vascular endo endothelial thelial dysfunction[J]. Prog cardioras Dis,1997,39(4):325-342.
  • 4Anderson TJ.Assessment and treatment of endothelial dysfunction in humans[J].J Am coll Cardiol, 1999,34(3):631-638.
  • 5何兆初,苏诚坚,孙明,黄帼英,潘洁贞.原发性高血压心血管重构的机制及氯沙坦的干预研究[J].岭南心血管病杂志,2000,6(4):231-233. 被引量:8
  • 6Cottone S, Vadola A, Vella MC, etal. change of plasma endothelin and growth factor levels, and left ventricular mass, after chronic AT1-receptor blockade in human hypertension[J]. Am J Hypertens, 1998,11(5):548-553.
  • 7Mancini GB. Role of angiotensin-coverting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease[J]. Am J Med, 1998,10S(1A):40S-47S.
  • 8李淑梅,吴平生,郭志刚,钟世顺,张远慧,刘伊丽,赖文岩.氯沙坦抑制自发性高血压大鼠血管合成醛固酮及CYP11B_(2)mRNA表达[J].中华心血管病杂志,2000,28(6):467-469. 被引量:10
  • 9Prasad A, Tupas-Habib T, Scherke NH,etal.Acute and chronic antiotensin-1 receptor angagonism reserves endothetial dysfunction in atherosclerosis[J].Circulation,2000,101(20):2349-2354.

二级参考文献12

  • 1陈松苍,吴可贵,陈达光,林好学,赖鹏斌,苏津自,林明,王华军.高血压左心室肥厚患者的心肌缺血和室性心律失常[J].中华心血管病杂志,1996,24(6):441-444. 被引量:21
  • 21,Black MY, Bertram JF, Campell, JH, et al. Angiotenisn Ⅱ induces cardiovascular hypertrophy in parindopril-treated rats. J Hypstens. 1995, 13:683
  • 32,The sixth report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997, 57(21):113
  • 44,Jamil Mayet, Alice V. Stanton, Anne-Murie Sinclair, et al. The effects of antihypertensive therapy on carotid vascular structure in man. Cardiovascular Research. 1995, 30: 147
  • 56,Roman MMJ, Pickering TG, Pini R, et al. Determinants of cardiac and vascular hypertrophy in hypertension. Hypertersion. 1995, 26:269
  • 67,Gabor M. Rubangi. The role of endothelium in cardiovascular homeostasis and disease. J Cardiovasc Pharmacol, 1993, 22(Suppl 4):S1
  • 78,Clapham DE. Calcium Signaling. Cell. 1995, 80:259
  • 89,Alicia Rivera, Paul R. Conlin. Goren H, et al. Elevated lymphocyte cytosolic calcium in a subgroup of essential hypertensive subjects. Hypertension. 1996, 28:213
  • 9Pingsheng W,Horm Res,1998年,50卷,2831页
  • 10Gomez Sanchez E P,Steroids,1996年,6卷,184页

共引文献13

同被引文献26

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部